logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Pascale Tomasini

Assistance Publique-Hopitaux de Marseille
H指数:31
被引数:4,402

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib
Clinical Lung Cancer
IF3.3
2025-12-200
PRE
Pascale Tomasini; Oscar Juan-Vidal; Raffaele Califano; Chien-Chung Lin; Pauline Hulo; Christophe Dooms; Jian Fang; Ana Blasco; Dariusz Kowalski; Jorge Salinas; Govind Babu; Tho Lye Mun; Alessandra Bearz; Veerle Surmont; Clarissa Baldotto; Richu Sharma; Oscar Arrieta; Katarzyna Stencel; Cynthia Card; Alona Zer
The evolving role of Hospital Oncology Pharmacists (HOPs) in assessing therapeutic innovations and managing toxicities in cancer care

医院肿瘤药师（HOPs）在评估治疗创新和管理癌症护理毒性方面的演变角色

Annales Pharmaceutiques Francaises
IF1.1
2025-12-010
PRE
Ranchon, Florence; Slimano, Florian; Ayyoub, Maha; Berard, Charlotte; Grand, Anais; Kroemer, Marie; Paoletti, Xavier; Schwiertz, Verane; Tomasini, Pascale; Bardin, Christophe; Raffoux, Emmanuel; Rioufol, Catherine; Chevrier, Regine; Pourroy, Bertrand; Cazin, Jean-Louis
Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial

增强型与标准皮肤管理联合阿曼曲妥珠单抗-拉泽替尼在EGFR突变型晚期NSCLC中的应用比较：COCOON全球随机对照试验

Journal of Thoracic Oncology
IF20.8
2025-09-090
OAAI
Byoung Chul Cho; Weimin Li; Alexander I. Spira; Maxwell Sauder; Jill Feldman; Farastuk Bozorgmehr; Milena Mak; Janellen Smith; Pei Jye Voon; Baogang Liu; Panwen Tian; Jiunn-Liang Tan; Cheng-Ta Yang; Jin-Yuan Shih; Nuri Karadurmus; Juan Esteban Cundom; Glaucio Bertollo; Irfan Cicin; Jorge Nieva; Ana Laura Ortega-Granados; Pascale Tomasini; Danny Nguyen; Enriqueta Felip; Julia Schuchard; Sean P. Murphy; Bailey G. Anderson; Tonatiuh Romero; Yichuan Xia; Shubin Sheng; Joshua M. Bauml; Parthiv J. Mahadevia; Julian Kam; Mehregan Nematian-Samani; Jairo Simoes; Mark Wildgust; Nicolas Girard
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study

Amivantamab在晚期NSCLC和MET外显子14跳跃突变参与者中的应用: CHRYSALIS研究的最终结果

Journal of Thoracic Oncology
IF20.8
2025-05-160
PREAI
Matthew G. Krebs; Byoung Chul Cho; Sandrine Hiret; Ji-Youn Han; Ki Hyeong Lee; Casilda Llácer Pérez; Filippo De Braud; Eric B. Haura; Rachel E. Sanborn; James Chih-Hsin Yang; Catherine A. Shu; Koichi Goto; Makoto Nishio; Jun Zhao; Zhijie Wang; Pascale Tomasini; Enriqueta Felip; Jonathan W. Goldman; Sai-Hong Ignatius Ou; Michael Boyer; Grace Gao; Siyang Qu; Joshua C. Curtin; Xuesong Lyu; Robert W. Schnepp; Priya Kim; Meena Thayu; Roland E. Knoblauch; Patricia Lorenzini; Mahadi Baig; Alexander I. Spira; Natasha B. Leighl
Precision immuno-oncology for advanced non-small cell lung cancer (NSCLC) patients with PD-(L)1 inhibitors resistance (PIONeeR): A phase Ib/IIa clinical trial targeting identified resistance pathways

针对经PD-(L)1抑制剂治疗失败的晚期非小细胞肺癌（NSCLC）患者的精准免疫肿瘤学研究（PIONeeR）：一项靶向已知耐药通路的Ib/IIa期临床试验

ANNALS OF ONCOLOGY
IF65.4
2024-09-012
PRE
Tomasini, P.; Cropet, C.; Jeanson, A.; Perol, M.; Mazieres, J.; Fontaine, C.; Rabeau, A.; Meurer, M.; Greillier, L.; Le Ray, M.; Laborde, L.; Cohen, A.; Martin, V.; Roumieux, M.; Monville, F.; Vivier, E.; Perol, D.; Chabaud, S.; Barlesi, F.
Long circulating-free DNA fragments predict early-progression (EP) and progression-free survival (PFS) in advanced carcinoma treated with immune-checkpoint inhibition (ICI): A new biomarker

循环游离DNA片段可预测接受免疫检查点抑制治疗的晚期癌患者的早期进展（EP）和无进展生存期（PFS）：一种新的生物标志物

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Salas, S.; Nguyen-Phuong, L.; Ginot, F.; Greillier, L.; Tomasini, P.; Boutonnet, A.; Deville, J. L.; Fina, F.; Benzekry, S.
Amivantamab in wild-type advanced non-small cell lung cancer after disease progression on checkpoint inhibition and chemotherapy: Results from the phase 1b CHRYSALIS study
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Cho, Byoung Chul; Goldman, Jonathan; Leighl, Natasha; De Braud, Filippo; Lee, Ki Hyeong; Ghiringhelli, Francois; Garrido, Pilar; Peguero, Julio; Besse, Benjamin; Cassier, Philippe; Girard, Nicolas; de Miguel, Maria; Alvarez, Rosa; Greystroke, Alastair; Ohe, Yuichiro; Hsia, Te-Chun; Curtin, Joshua C.; Chowdhury, Sanjib; Lyu, Xuesong; Gao, Grace; Qu, Siyang; Lorenzini, Patricia; Kapoor, Aastha; Kim, Priya; Baig, Mahadi; Thayu, Meena; Knoblauch, Roland E.; Hiret, Sandrine; Tomasini, Pascale
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Amivantamab联合化疗联合或不联合lazertinib治疗奥希替尼治疗EGFR突变晚期NSCLC后疾病进展: III期MARIPOSA-2研究的主要结果

ANNALS OF ONCOLOGY
IF65.4
2024-01-01101
OA
Passaro, A.; Wang, J.; Wang, Y.; Lee, S. -H.; Melosky, B.; Shih, J. -Y.; Wang, J.; Azuma, K.; Juan-Vidal, O.; Cobo, M.; Felip, E.; Girard, N.; Cortot, A. B.; Califano, R.; Cappuzzo, F.; Owen, S.; Popat, S.; Tan, J. -l.; Salinas, J.; Tomasini, P.; Gentzler, R. D.; William, W. N.; Reckamp, K. L.; Takahashi, T.; Ganguly, S.; Kowalski, D. M.; Bearz, A.; MacKean, M.; Barala, P.; Bourla, A. B.; Girvin, A.; Greger, J.; Millington, D.; Withelder, M.; Xie, J.; Sun, T.; Shah, S.; Diorio, B.; Knoblauch, R. E.; Bauml, J. M.; Campelo, R. G.; Cho, B. C.
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary

sotorasib对KRAS G12C-mutated非小细胞肺癌患者的长期益处: 简明语言总结

FUTURE ONCOLOGY
IF2.6
2023-11-271
OA
Dy, Grace K.; Govindan, Ramaswamy; Velcheti, Vamsidhar; Falchook, Gerald S.; Italiano, Antoine; Wolf, Juergen; Sacher, Adrian G.; Takahashi, Toshiaki; Ramalingam, Suresh S.; Dooms, Christophe; Kim, Dong-Wan; Addeo, Alfredo; Desai, Jayesh; Schuler, Martin; Tomasini, Pascale; Hong, David S.; Lito, Piro; Tran, Qui; Jones, Simon; Anderson, Abraham; Hindoyan, Antreas; Snyder, Wendy; Skoulidis, Ferdinandos; Li, Bob T.

研究方向

暂未获取到该数据
L
Laurent Greillier
H 指数:41论文数:498被引数:9,246
F
Fabrice Barlési
H 指数:99论文数:1,480被引数:7.1万
C
Céline Mascaux
H 指数:0论文数:0被引数:76
P
P. Thomas
H 指数:73论文数:812被引数:2.2万
N
Nicolas Girard
H 指数:81论文数:913被引数:3.9万
N
Natasha B. Leighl
H 指数:87论文数:963被引数:4.4万
B
Byoung Chul Cho
H 指数:106论文数:1,592被引数:7.0万
L
L’Houcine Ouafik
H 指数:47论文数:295被引数:7,630
A
Alice Mogenet
H 指数:5论文数:31被引数:104
J
Julien Mazières
H 指数:91论文数:996被引数:4.8万